Mobile Technology and Motivational Interviewing in Type 2 Diabetes Patients

Quality of Life Clinical Trial

Official title:

The Effect of Motivational Interview Empowered by Mobile Technology on Self Management, Quality of Life and Satisfaction Level in Type 2 Diabetic Patients

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05919706
• Other study ID #: Diabetes Mellitus and Mobile
• Status: Completed
• Phase: N/A
• Start date: October 6, 2022
• Est. completion date: February 3, 2023

Study information

• Verified date: June 2023
• Source: Inonu University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Type 2 diabetes patients were divided into experimental and control groups. Patients in the control group received regular nursing care, while those in the experimental group received MI, which is empowered by game-based mobile technology. Pre-test, post-test and follow-up test self-management, quality of life and satisfaction levels scores were determined.

Description:

A randomized controlled and experimental study design was used to conduct this research on 64 patients with Type 2 DM. Purpose of this study was to explore how motivational interviewing powered by game-based mobile technology affected self-management, quality of life, and satisfaction in Type 2 diabetes patients.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 64
• Est. completion date: February 3, 2023
• Est. primary completion date: February 3, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Being 18 years or older,

• Having a diagnosis of Type 2 Diabetes Mellitus according to the ADA diagnostic criteria,

• Being on oral antidiabetic and/or insulin therapy,

• Having a smart phone and knowing how to use it,

• Internet connection (to install mobile technology application),

• Not having participated in motivational interviewing (MG) training before,

• Not having vision and hearing problems,

• Not having a communication problem,

• To be able to read, write and speak Turkish,

• Volunteering to participate in the study and continue the study process.

Exclusion Criteria:

• Having a diagnosis of Type 1 and/or Gestational Diabetes Mellitus,

• Having serious health problems that prevent participation in motivational interviewing,

• Using steroid therapy,

• Having complications that may develop in the long term due to diabetes and having advanced retinopathy, neuropathy, amputation history or active foot wound,

• Having mental confusion, having any psychiatric problems and/or using a psychiatric drug,

• Being unwilling to participate in the study and/or not wanting to continue the study process.

Related Conditions & MeSH terms

• Diabetes Mellitus, Type 2
• Gaming
• Mobile Technology
• Motivational Interviewing
• Quality of Life
• Self-Management
• Type 2 Diabetes Mellitus

Intervention

Behavioral:
• Patient Education with Game-Based Mobile Technology and Motivational Interviewing
Education program, game-based mobile technology and motivational interview were applied to the patients in the experimental group. The patients' self-management, quality of life, and satisfaction level scores for the intervention were determined.

Locations

Country	Name	City	State
Turkey	Bingol State Hospital	Bingöl	Centrer

Sponsors (1)

Lead Sponsor	Collaborator
Inonu University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	DSMQ	The scale is of a four-point Likert type. The scale has 4 sub-dimensions as "Glucose Management, Diet Control, Physical Activity, Health-Care Use" and a total score. The lowest score of the scale is 0 points and the highest score is 10 points. The higher the score, the higher the diabetes self-management.	Last 8 weeks
Primary	SF-36	The scale consists of 36 items and 8 sub-dimensions. 8 sub-dimensions have 2 summary sub-dimensions as "Physical Health and Mental Health". There is no total score in the scale. A score between 0-100 is evaluated with sub-dimensions (0: Poor Health, 100: Good Health). Low scores on the scale indicate poor health, while high scores indicate good health.	Last 4 weeks